Wyeth Touts PE Efficacy Claims In Comments To FDA
This article was originally published in The Tan Sheet
Executive Summary
A letter to the editor in the July Journal of Allergy & Clinical Immunology questioning phenylephrine efficacy inappropriately downplayed positive data in favor of negative studies, Wyeth Consumer Healthcare states in comments submitted to FDA Nov. 16